Search This Blog

Wednesday, May 13, 2026

Virus in the Dust: Exposing the Fabricated Contagion of Andes Hantavirus

 By Peter A. McCullough, MD, MPH

As an epidemiologist, I know contact tracing studies are inherently flawed. So I was immediately suspicious of the claim that Hantavirus Andes strain had jumped from zoonotic to human-to-human spread. This claim is very likely to be false and should not be the basis for the global public health response to the Hantavirus outbreak from rodents on board the MV Hondius.

🔬 Scientific Evaluation: Reassessing Transmission Pathways of the Andes Orthohantavirus


1. Introduction

The Andes orthohantavirus (ANDV) is uniquely recognized within the Hantaviridae family for its putative human-to-human transmission. While this claim has become a foundational pillar in epidemiological modeling and public health policy, the scientific evidence base remains largely speculative. This report critically examines the methodological limitations inherent in existing contact tracing studies and argues that the assertion of direct human-to-human transmission lacks the rigorous validation required by controlled, empirical investigation.


2. The Confounding Variable: Environmental Exposure

The primary challenge in attributing ANDV infection to human-to-human contact lies in the ubiquity of the virus’s primary reservoir, the long-tailed pygmy rice rat (Oligoryzomys longicaudatus).

🏚️ The “Common Environment” Hypothesis

Existing epidemiological studies frequently rely on retrospective contact tracing to establish transmission chains. However, these investigations often fail to adequately isolate participants from shared environmental risks.

  • Aerosolized Particulates: ANDV, like other hantaviruses, is primarily shed in the urine, feces, and saliva of infected rodents. These excretions dry into dust, which can remain infectious for extended periods in enclosed spaces.

  • Inadequate Site Assessment: In many documented “human-to-human” cases, the transmission occurred within households or rural dwellings. These environments are frequently contaminated with rodent excreta. Current contact tracing methodologies often assume that if no rodent was seen, no rodent exposure occurred. This assumption ignores the reality that microscopic viral particles in house dust are sufficient for inhalation or mucosal contact.

A rigorous scientific framework must rule out the possibility that both the “index” case and the “secondary” case were independent victims of the same contaminated environmental reservoir before concluding that direct transmission took place. In the absence of comprehensive environmental sampling—specifically, testing dust and surfaces for viral RNA at the time of exposure—the environmental transmission hypothesis cannot be dismissed.

4/1/26 Ship departs likely with infected rodents on board

4/11/26 Dutch man dies on ship

4/24/26 Spouse of Dutch man disembarks in St Helena with his body and dies shortly afterwards

4/24/26 Ill British man disembarks and airlifted to Johannesburg improved now out of ICU

4/24/26 n=28 passengers get off and remain well except Swiss man

4/24/26 Swiss man with mild symptoms has Hantavirus found and genotyped (below)

5/2/26 German dies on ship in harbor at Cape Verde (authorities refused to let the ship dock at the port because of the suspected hantavirus outbreak)

5/2/26 WHO locks passengers in cabins with infected rodents/ventilation system, fresh air on deck not permitted

5/10/26 Remaining passengers disembark in Canary Islands

5/10/26 Ill French woman flown from Tenerife to a France ICU (first victim from WHO lockdown)

5/11/26 MV Hondius, still virus-contaminated, likely with rodent reservoir sets sail with 30 crew and medical personnel to Rotterdam, Netherlands


3. The Absence of Empirical Validation

The standard for establishing a novel transmission pathway is high. To definitively conclude that a virus has transitioned from zoonotic to human-to-human spread, one must move beyond correlational field data. Toledo et al evaluated the published studies and concluded that person-to-person spread had not been demonstrated.

🚫 Lack of Challenge Studies

Currently, there exists a complete absence of isolated human challenge studies. While ethical constraints are understood, the lack of clinical validation leaves a significant interpretive gap.

  • Biologic Plausibility vs. Proof: While viral shedding in human bodily fluids has been documented, the viability and infectiousness of the virus via human-to-human routes remain unproven.

  • The Zoonotic Baseline: The Hantavirus genus is characterized by its strict association with rodent hosts. For a virus to jump from a zoonotic cycle to sustained or even sporadic human-to-human transmission, distinct evolutionary adaptations are typically required—none have been found in the current strain. The current literature has yet to provide a robust, mechanistic explanation of how ANDV bypasses the natural species barrier so effectively in human populations without intermediate animal hosts.


4. Methodological Critiques of Current Surveillance

The widespread acceptance of human-to-human ANDV transmission relies heavily on the strength of contact tracing data. Yet, these studies suffer from significant selection bias:

  1. Recall Bias: Participants in high-stress, post-outbreak scenarios are naturally prone to recall interactions with other people, while often overlooking mundane environmental exposures like sweeping a floor or entering an unventilated storage room.

  2. Lack of Genomic Precision: While viral sequencing has shown links between cases, it does not distinguish between a direct human-to-human transmission chain and a shared, localized environmental source that mutated or persisted in a specific rodent population.


5. Conclusion

The assertion that Andes orthohantavirus has definitively transitioned to human-to-human transmission is premature and conceptually fragile. When environmental contamination—a well-established risk factor for all hantaviruses—is not meticulously excluded, the “transmission” observed in clusters may simply be a reflection of communal exposure to a shared, contaminated micro-environment. Until controlled studies are performed and environmental variables are rigorously accounted for, the scientific community should maintain a skeptical perspective on the viability of human-to-human spread and should not participate in global fear-mongering over a hantavirus contagion.

https://www.thefocalpoints.com/p/virus-in-the-dust-exposing-the-fabricated

Michael Burry is not a believer: ‘For any stocks going parabolic reduce positions almost entirely’

 Michael Burry urged investors to scale back exposure to surging technology stocks, saying the current market environment has reached historically dangerous extremes reminiscent of prior speculative bubbles.

The famed investor, best known for predicting the 2008 housing collapse, said investors should “reject greed” as enthusiasm around artificial intelligence and momentum-driven trades pushes valuations sharply higher.

“An easier way for most is to simply reduce exposure to stocks, to tech stocks in particular. For any stocks going parabolic reduce positions almost entirely,” Burry wrote in a Sunday Substack post.

Burry has been warning for months that the stock market’s AI fixation increasingly resembles the final stages of the dot-com bubble. Last week, he compared the recent trajectory of the Philadelphia Semiconductor Index (SOX) to the run-up that preceded the collapse of technology stocks in March 2000, saying the current environment feels like “the last months of the 1999-2000 bubble.”

Burry said he is maintaining “a significant leveraged short position” against a portfolio of companies he views as depressed and cheap, a similar strategy he employed in 2000.

However, Burry warned that directly betting against the rally through short selling is risky and impractical for most investors, particularly as bearish trades have become increasingly expensive.

“Shorting is not the answer. It is not something most people should ever do,” he said. “Right now it is expensive, in general, to buy put options and directly shorting stocks can still cause significant pain.”

The comments add to a growing debate on Wall Street over whether the AI-driven rally in U.S. equities has become detached from fundamentals. Major stock indexes have repeatedly hit record highs despite the ongoing war in the Middle East as investors pile into semiconductor makers and megacap companies.

“The idea is to raise cash, and prepare to put it to work when it makes more sense to do so,” Burry wrote. “History tells us that even if the party goes on for another week, month, three months or year, the resolution will be to much lower prices.”

https://www.cnbc.com/2026/05/11/michael-burry-is-not-a-believer-for-any-stocks-going-parabolic-reduce-positions-almost-entirely.html

Extortion Using Smart Glasses Is a Thing Now



There’s a growing number of reasons to be skeptical about camera-equipped smart glasses, and you can now add extortion to that list. According to a report from the BBC, a woman who asked not to be named was recently filmed covertly while shopping in London by a man wearing smart glasses. That interaction was later posted to social media, where it racked up tens of thousands of views.


That story, unfortunately, isn’t a new phenomenon. As other investigations have noted, smart glasses like the Ray-Ban Meta AI glasses are used regularly by men—specifically men—to record women discreetly for content purposes. What makes this particular case reported by the BBC worse is that the man in question allegedly asked for money in exchange for taking the video down, claiming that removal was a “paid service.”

According to the BBC, the video was eventually taken down after being reported for violating TikTok’s rules on harassment and bullying, and the man’s account was banned. The footage was, however, later reposted to a different social media site. The BBC reached out to the person who filmed the interaction, who, of course, denies trying to extort anyone, and the police—who were reportedly contacted—say they don’t have enough information to launch an investigation.© Raymond Wong / Gizmodo

In a nutshell, this is exactly the type of thing that has people up in arms about smart glasses as a category. While recording people discreetly can be done with a phone, holding a glass slab in front of someone’s face is a lot more likely to be clocked. The fact that the woman in this incident didn’t know she was being filmed at all should tell you a lot, since it means the privacy light (and LED that lights up when you record) on the smart glasses being used was obscured or not visible enough to catch her attention.


For now, it remains to be seen whether makers of smart glasses have a real solution for preventing spying outside of shipping smart glasses that don’t have cameras for photography or video recording. Wherever there’s a camera, there’s going to be someone pointing it at something they shouldn’t.

FDA Warns of New Blood Cancers With Sarcoma, Lymphoma Drug

 The FDA on Monday alerted clinicians about the risk of new primary hematologic malignancies in patients treated with tazemetostat (Tazverik, Ipsen), a sarcoma and lymphoma drug now being pulled from global markets.

The risk was known when the EZH2 inhibitor was granted accelerated approvals in 2020, with an incidence of 1.7%. But new data from the SYMPHONY-1 trial found a rate approaching 6% over a median treatment duration of 15.8 months.

"It was determined that the risks of treatment with Tazverik outweigh its benefits," the FDA said.

Of the 318 follicular lymphoma patients in the randomized study -- evaluating lenalidomide (Revlimid) and rituximab with or without tazemetostat -- 18 patients (5.7%) developed a second hematologic malignancy in the tazemetostat arm versus none in the control arm. Three died and the new malignancies remain unresolved for 14 patients.

Most of the cases were myelodysplastic syndromes (MDS) or acute myeloid leukemia, while others included B-cell acute lymphoblastic leukemia and clonal cytopenia of undetermined significance.

"Treatment-emergent acute leukemias and MDS are serious and life-threatening disorders that are not expected to be reversible," the FDA stated.

Trial participants had been taking the drug for 1 to 3 years, and the new malignancies started as early as 7.5 months after beginning tazemetostat, while some occurred after treatment cessation.

Drugmaker Ipsen announced the U.S. and global withdrawal of tazemetostat in March based on the emerging safety concern. An independent data monitoring committee recommended that all trial participants discontinue tazemetostat immediately, but SYMPHONY-1 will remain open for long-term safety follow-up. Ipsen has discontinued all other active trials of the EZH2 inhibitor and any expanded access programs.

Tazemetostat originally received accelerated approvals from the FDA for metastatic or locally advanced epithelioid sarcoma and for previously treated follicular lymphoma in patients with an EZH2 mutation. As always, drugs approved under the pathway are subject to confirmation of clinical benefit.

https://www.medpagetoday.com/hematologyoncology/othercancers/121222

These States Are Watching for Potential Hantavirus Cases

 

Some people who may have been exposed to a hantavirus that can transmit from human to human returned to the U.S. before the outbreak aboard a cruise ship was known.

This includes seven Americans who disembarked the ship on the remote island of St. Helena on April 24. MedPage Today broke that story last week.

It also includes at least nine Americans who were on the same plane from St. Helena to Johannesburg as the widow of the first cruise ship passenger who died. That woman was symptomatic during the flight, and died not long after landing in South Africa.

State health officials have contacted these people and have advised them to quarantine as best they can, with home monitoring and daily symptom and fever checks. According to CDC's interim guidance, they are all high risk, as they were either on the ship as of April 6, when the first patient died, or were seated close to the symptomatic passenger on the plane.

They've been asked to delay nonessential medical care, skip travel plans, and work from home.

There are also 18 passengers from the ship who were recently repatriated; 16 of them are at the University of Nebraska Medical Center in Omaha, while two were flown to a biocontainment unit at Emory University in Atlanta after one developed symptoms. That person has since tested negative for the disease. The other person was their partner.

Of the 16 people who remain in Nebraska, one tested positive for the virus. That person was an oncologist who helped manage sick passengers on board after the ship's doctor became sick. He is now in the facility's biocontainment unit, where he remains asymptomatic.

The other 15 passengers are in Nebraska's quarantine unit, where they will be assessed, and eventually they will have the choice about where to quarantine -- either at the facility or at home, if it's determined that can be done safely.

Unfortunately, the quarantine period is 42 days, which is thought to be the upper limit of the incubation period for the Andes virus, the strain of hantavirus involved in the outbreak. That can seem like a long time to spend in a quarantine facility, but it does guarantee access to the nation's top experts in outbreak response and treatment.

"If I was exposed to this and I had the option to stay in a quarantine unit proximate to that care, I would definitely take that, because you're putting yourself in a position, if you were to turn positive, to take advantage of all those things that will give you the best chance of survival," said Michael Wadman, MD, an emergency physician and medical director of Nebraska's quarantine unit.

Here's where patients are being monitored:

Arizona: one passenger

California: one passenger; one air travel

Georgia: four passengers

Kansas: three air travel

Maryland: two air travel

Minnesota: one air travel

New Jersey: two air travel

Nebraska: 16 passengers; one tested positive

Texas: two passengers

Virginia: one passenger

https://www.medpagetoday.com/infectiousdisease/publichealth/121244